
Aveed’s Impact on Liver Function in American Males with Hypogonadism: A Two-Year Study
Reading Time: < 1 minute Introduction Aveed, a testosterone undecanoate injection developed by Endo Pharmaceuticals, has been widely used for the treatment of hypogonadism in American males. While effective in increasing testosterone levels, the long-term impact of Aveed on liver function remains a critical area of concern. This article presents a comprehensive analysis of the biochemical effects of Aveed on liver function over a two-year period in American males, highlighting the importance of monitoring and managing potential hepatic side effects. Study Design and Methodology The study involved 200 American males diagnosed with hypogonadism, aged between 30 and 60 years, who were administered Aveed at the...